Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-09 Sale |
2022-02-11 6:10 pm |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
397 | $36.3 | $14,411 | 65,848 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-05 8:56 pm |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $105.04 | $3,734,075 | 118,295 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-09 Option Award |
2022-02-11 6:10 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
62,400 | $0 | 65,848 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 8:56 pm |
N/A 2030-03-01 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $0 | 118,295 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-05 8:56 pm |
N/A N/A |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
35,550 | $51.28 | 118,295 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:55 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer |
21,148 | $0 | 21,148 (Direct) |
View |